Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.
The owners and staff of Woodstock Infusions (L-R): manager Tania Cawthron, owner and registered nurse Kim Rice, founder and owner Marc Baumslag and registered nurse Anna Schlosser. (Photos by Lauren ...
Celebrities and wellness influencers are getting routine NAD+ infusions as an anti-aging hack, but are these expensives IV drips worth the hype?
Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech (OTCPK:SGBCF) to jointly develop and market a biosimilar version of Darzalex, a multiple ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...
Panelists discuss how oral iron therapy, although convenient and cost-effective, has significant limitations, including ...
Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback